UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 20,588 Shares of Revvity Inc. $RVTY

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in Revvity Inc. (NYSE:RVTY) by 4.3% in the second quarter, Holdings Channel.com reports. The firm owned 497,157 shares of the company’s stock after acquiring an additional 20,588 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Revvity were worth $55,314,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of RVTY. EdgePoint Investment Group Inc. grew its stake in shares of Revvity by 3.1% during the first quarter. EdgePoint Investment Group Inc. now owns 8,800,863 shares of the company’s stock worth $771,044,000 after purchasing an additional 265,204 shares during the period. Jupiter Topco LLC bought a new stake in shares of Revvity during the second quarter worth $961,017,000. Price T Rowe Associates Inc. MD increased its holdings in Revvity by 5.3% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,606,637 shares of the company’s stock worth $832,693,000 after purchasing an additional 434,570 shares in the last quarter. Janus Henderson Group PLC grew its holdings in shares of Revvity by 2.3% during the first quarter. Janus Henderson Group PLC now owns 8,348,127 shares of the company’s stock worth $731,386,000 after buying an additional 186,956 shares in the last quarter. Finally, BlackRock Inc. bought a new position in shares of Revvity during the 2nd quarter worth approximately $852,070,000. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Trading Up 3.5%

Shares of Revvity stock opened at $130.98 on Thursday. The firm’s 50 day moving average is $115.72 and its 200 day moving average is $101.80. The firm has a market capitalization of $14.62 billion, a PE ratio of 62.37, a price-to-earnings-growth ratio of 2.30 and a beta of 1.09. The company has a current ratio of 1.80, a quick ratio of 1.50 and a debt-to-equity ratio of 0.36. Revvity Inc. has a 1 year low of $81.22 and a 1 year high of $131.75.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.20. The company had revenue of $729.69 million during the quarter, compared to analysts’ expectations of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%.Revvity’s revenue was down 1.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.18 EPS. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Equities research analysts forecast that Revvity Inc. will post 5.36 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be given a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity’s dividend payout ratio is 13.33%.

Wall Street Analyst Weigh In

RVTY has been the subject of several analyst reports. Wall Street Zen cut Revvity from a “buy” rating to a “hold” rating in a report on Sunday, August 16th. Zacks Research upgraded shares of Revvity from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 4th. Wolfe Research started coverage on Revvity in a research note on Tuesday, June 2nd. They set a “peer perform” rating on the stock. Barclays raised their price target on shares of Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. Finally, Weiss Ratings upgraded Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 30th. Three analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $110.58.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.